Kinetics of the Solution-Mediated Polymorphic Transformation of Organic Compounds

被引：7
|
作者：
Wantha, Lek [1 ]
机构：
[1] Burapha Univ, Fac Engn, Dept Chem Engn, 169 Long Hard Bangsaen Rd, Chon Buri 20131, Thailand
来源：
CURRENT PHARMACEUTICAL DESIGN | 2018年 / 24卷 / 21期
关键词：
Polymorphism; organic compound; crystallization from solution; kinetics; solution-mediated polymorphic transformation; process modelling; L-GLUTAMIC ACID; ACTIVE PHARMACEUTICAL INGREDIENTS; POPULATION BALANCE MODEL; DRUG-DELIVERY SYSTEM; FORM III PIRACETAM; SOLID-STATE; NUCLEATION KINETICS; CRYSTALLIZATION BEHAVIOR; DISSOLUTION KINETICS; PHASE-TRANSFORMATION;
D O I：
10.2174/1381612824666180601093228
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Polymorphism is a behavior of a substance to crystallize into more than one district crystal structures. Preferential formation of a polymorph depends strongly on the kinetics of the relevant mechanisms. Solution-mediated polymorphic transformation is an important mechanism in crystallization of organic compounds from solution. Knowing its kinetics allows us to understand the process and control the polymorphic formation. In this review, concepts, kinetics, and process modeling of crystallization and solution-mediated polymorphic transformation are examined and summarized.
引用
收藏
页码：2383 / 2393
页数：11
相关论文
共 50 条
  • [41] Prominent inhibitory effect of 2-hydroxybutyl-β-cyclodextrin on solution-mediated polymorphic transition of chlorpropamide
    Ishiguro, Takako
    Hirayama, Fumitoshi
    Iohara, Daisuke
    Uekama, Kaneto
    CHEMISTRY LETTERS, 2008, 37 (08) : 816 - 817
  • [42] Solution-Mediated Phase Transformation of a Hydrate to its Anhydrous Form of Donepezil Hydrochloride
    Liu, Tiantian
    Wang, Bochao
    Dong, Weibing
    Gong, Junbo
    CHEMICAL ENGINEERING & TECHNOLOGY, 2013, 36 (08) : 1327 - 1334
  • [43] SOLVENT EFFECTS ON KINETICS OF SOLUTION-MEDIATED TRANSITION OF STEARIC-ACID POLYMORPHS
    SATO, K
    SUZUKI, K
    OKADA, M
    GARTI, N
    JOURNAL OF CRYSTAL GROWTH, 1985, 72 (03) : 699 - 704
  • [44] Efficient co-crystal screening using solution-mediated phase transformation
    Zhang, Geoff G. Z.
    Henry, Rodger F.
    Borchardt, Thomas B.
    Lou, Xiaochun
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (05) : 990 - 995
  • [45] Size-dependent solution-mediated phase transformation of piroxicam monohydrate particles
    Yao, Changlin
    Wang, Lei
    Wang, Xinyuan
    Tao, Xutang
    CRYSTENGCOMM, 2021, 23 (16) : 2928 - 2932
  • [46] Solution-mediated phase transformation of anhydrous to dihydrate carbamazepine and the effect of lattice disorder
    Murphy, D
    Rodríguez-Cintrón, F
    Langevin, B
    Kelly, RC
    Rodríguez-Hornedo, N
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 246 (1-2) : 121 - 134
  • [47] Solution-mediated crystallization of amorphous azithromycin
    Stieger, N.
    Joubert, A.
    Liebenberg, W.
    PHARMAZIE, 2017, 72 (08): : 447 - 448
  • [48] Solution-Mediated Transformation Kinetics of Calcium Sulfate Dihydrate to α-Calcium Sulfate Hemihydrate in CaCl2 Solutions at Elevated Temperature
    Fu, Hailu
    Jiang, Guangming
    Wang, Hao
    Wu, Zhongbiao
    Guan, Baohong
    INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 2013, 52 (48) : 17134 - 17139
  • [49] Simultaneous Effects of Multiple Factors on Solution-Mediated Phase Transformation: A Case of Spironolactone Forms
    Jia, Lihong
    Zhou, Ling
    Du, Wei
    Zhou, Lina
    Zhang, Meijing
    Hou, Baohong
    Bao, Ying
    Wang, Zhao
    Yin, Quxiang
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2018, 22 (07) : 836 - 845
  • [50] Effect of binders on polymorphic transformation kinetics of carbamazepine in aqueous solution
    Otsuka, M
    Ohfusa, T
    Matsuda, Y
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2000, 17 (03) : 145 - 152
12345